Drug Shortage Report for TRULICITY

Last updated on 2025-06-10 History
Report ID 211401
Drug Identification Number 02448599
Brand name TRULICITY
Common or Proper name dulaglutide
Company Name ELI LILLY CANADA INC
Market Status MARKETED
Active Ingredient(s) DULAGLUTIDE
Strength(s) 0.75MG
Dosage form(s) SOLUTION
Route of administration SUBCUTANEOUS SUBCUTANEOUS
Packaging size 4 x 0.5 mL single-use prefilled pen
ATC code A10BJ
ATC description BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS
Reason for shortage Demand increase for the drug.
Anticipated start date 2023-11-30
Actual start date 2023-11-30
Estimated end date 2025-06-30
Actual end date 2025-06-09
Shortage status Resolved
Updated date 2025-06-10
Company comments For any questions or concerns, please contact our Customer Response Centre at 1-888-545-5972 (Monday-Friday, 9 a.m. to 5 p.m. Eastern Time, excluding holidays).
Health Canada comments
Tier 3 Status No
Contact Address EXCHANGE TOWER, 130 KING STREET WEST
TORONTO, ONTARIO
CANADA M5X 1B1
Company contact information Lilly Canada’s Customer Response Centre 1-888-545-5972.

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2023-11-24 English Compare
v2 2023-11-24 French Compare
v3 2023-11-30 English Compare
v4 2023-11-30 French Compare
v5 2023-12-01 English Compare
v6 2024-01-04 English Compare
v7 2024-01-04 French Compare
v8 2024-03-20 English Compare
v9 2024-03-20 French Compare
v10 2024-05-09 English Compare
v11 2024-05-09 French Compare
v12 2024-08-23 English Compare
v13 2024-08-23 English Compare
v14 2024-08-23 French Compare
v15 2024-09-19 English Compare
v16 2024-09-19 French Compare
v17 2024-10-16 English Compare
v18 2024-10-16 French Compare
v19 2025-01-10 English Compare
v20 2025-01-10 French Compare

Showing 1 to 20 of 23